
- Applied Clinical Trials-06-01-2007
- Volume 0
- Issue 0
eShowcase: Adaptive Trials Simulation Toolkit
Adaptive Trials Simulation Toolkit Addresses New Ways to Run Clinical Trials
Adaptive Trials Simulation Toolkit Addresses New Ways to Run Clinical Trials
Tessella (Newton, MA) Adaptive Trials Simulation Toolkit contains a range of adaptive clinical trial models for simulating different adaptive methods from Phase I through Phase III. The first release includes a NDLM dose finder and a Seamless Phase II/III Simulator.
Adaptive Trials Simulation Toolkit
The NDLM dose finder, specific to Phase II trials, simulates trials run using a Bayesian Model that is updated with response data as the trial runs. The NDLM is fitted to the response data and used to estimate whether any dose will fit the target criteria and which dose is most likely. It allows the model to recommend whether to continue the trial and which doses to favor in randomization.
Seamless Phase II/III Simulator offers an interim analysis between the two phases, where the treatment arms to be retained are selected and the sample size for the next phase calculated. This step saves time between Phase II and III, and allows for smaller Phase III trials.
Tessella, (617) 454-1220,
Articles in this issue
over 18 years ago
Impact of EDC on Clinical Staff Rolesover 18 years ago
EDC: Caught in a Trapover 18 years ago
Saving Time and Moneyover 18 years ago
Project Management Evolves with Technologyover 18 years ago
Three-Dimensional Image Securityover 18 years ago
Under the Hood: EDCover 18 years ago
Demand Grows for Comparative Studiesover 18 years ago
EDC Progress Steady for Europe and Asiaover 18 years ago
Lessons from TGN 1412over 18 years ago
eCTD Guidance Takes Center StageNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.